Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan.
作者： Mark J. Ratain , Lalitha Iyer , Federico Innocenti
DOI:
关键词:
摘要: Amonafide and irinotecan are anticancer drugs representative of the clinical relevance of N-acetyltransferase (NAT) and uridine diphosphate glucuronosyltransferase (UGT) …
参考文章(58)
D. A. Bell, J. A. Taylor, M. A. Butler, E. A. Stephens, J. Wiest, L. H. Brubaker, F. F. Kadlubar, G. W. Lucier, Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis. ,vol. 14, pp. 1689- 1692 ,(1993) , 10.1093/CARCIN/14.8.1689
N Drakoulis, A Maurer, I Cascorbi, K Sperling, J Brockmöller, I Roots, Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. American Journal of Human Genetics. ,vol. 57, pp. 581- 592 ,(1995)
Laurent P. Rivory, Marc Vuilhorgne, Alain Commerçon, Susan M. Pond, Jacques Robert, Marie-Christine Haaz, Jean-François Riou, Serge Sable, Identification and Properties of a Major Plasma Metabolite of Irinotecan (CPT-11) Isolated from the Plasma of Patients Cancer Research. ,vol. 56, pp. 3689- 3694 ,(1996)
S Ohsako, T Deguchi, Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. Journal of Biological Chemistry. ,vol. 265, pp. 4630- 4634 ,(1990) , 10.1016/S0021-9258(19)39609-7
E Gupta, R Mick, J Ramirez, X Wang, T M Lestingi, E E Vokes, M J Ratain, Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients. Journal of Clinical Oncology. ,vol. 15, pp. 1502- 1510 ,(1997) , 10.1200/JCO.1997.15.4.1502
T Deguchi, Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. Journal of Biological Chemistry. ,vol. 267, pp. 18140- 18147 ,(1992) , 10.1016/S0021-9258(19)37164-9
John A. Benvenuto, Susan O'Brien, Michael Keating, Elihu Estey, Tyrone B. Felder, Miloslav Beran, Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia. Cancer Research. ,vol. 51, pp. 935- 938 ,(1991)
Mark J. Ratain, Everett E. Vokes, Timothy M. Lestingi, Jacqueline Ramirez, Rosemarie Mick, Elora Gupta, Metabolic Fate of Irinotecan in Humans: Correlation of Glucuronidation with Diarrhea Cancer Research. ,vol. 54, pp. 3723- 3725 ,(1994)
S S Legha, D Farquhar, R A Newman, R Shah, M L Vestal, T B Felder, M A McLean, K Lu, Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans. Drug Metabolism and Disposition. ,vol. 15, pp. 773- 778 ,(1987)
M J Ratain, G Rosner, S L Allen, M Costanza, D A Van Echo, I C Henderson, R L Schilsky, Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study Journal of Clinical Oncology. ,vol. 13, pp. 741- 747 ,(1995) , 10.1200/JCO.1995.13.3.741